Summary
We have defined three categories of cultured cell lines on the basis of their permissiveness (susceptibility to initial infection) to mouse hepatitis virus (MHV). Fully permissive L-2 cells gave rise to 100–1000-fold higher numbers of infectious centers than did semi-permissive LM, LM-K or C-1300 cells, whereas non-permissive Vero or C-6 cells were refractory to MHV infection. On an infected cell basis, there was no deficiency on the part of semi-permissive cell lines to replicate total viral RNA, viral polypeptides or progeny virions. Two of the semi-permissive cell lines (LM and LM-K) supported persistent MHV infection, while a third (C-1300) succumbed to lytic infection. LM and LM-K cells, but not C-1300 cells showed resistance to MHV-induced membrane fusion, even when placed in contact with fusion-active MHV-infected L-2 cells. The ability of a given cell to undergo fusion did not correlate with membrane lipid characteristics (unsaturated fatty acid and sterol content) which contribute to membrane “fluidity”. In order to more closely study the parameters of MHV-induced cell fusion, membranes were prepared from MHV-infected L-2 cells and monitored for their fusogenic potential with permissive L-2 cells, semi-permissive LM cells and non-permissive vero cells. Fusion was only observed with the permissive L-2 cells, and only when exogenous protease (trypsin or chymotrypsin) was added. When the membranes were prepared from 35S-methionine-labeled MHV-infected L-2 cells and subjected to protease treatment, the radiolabeled 180,000 dalton form of the E2-glycoprotein underwent proteolytic cleavage to yield a major product of approximately 90,000 daltons. Both trypsin and chymotrypsin were effective in this proteolytic cleavage and in activating membrane fusion. In a normally permissive, fusogenic infection of MHV in L-2 cells, the protease inhibitors TPCK and ZPCK, but not TLCK, were found to inhibit cell fusion. In MHV-infected L-2 cells, E2 was found almost exclusively as the 180,000 dalton form but turned over rapidly as shown by pulse-chase studies. TPCK and ZPCK but not TLCK inhibited turnover. The results suggest that L-2 cells contain a protease which cleaves at aromatic amino acids such as phenylalanine, and that this protease cleaves the 180,000 dalton form of the E2 to peptide fragments, one or more of which may activate cell fusion.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Anderson, R., Cheley, S., and Haworth-Hatherell, E. (1979). Virology 97, 492–494.
Atkinson, P. (1973). in “Methods in Cell Biology”, ed. Prescott, D., Vol. 7, pp. 157–188, Academic Press, N.Y.
Augusti-Tocco, G. and Sato, G. (1969). Proc. Natl. Acad. Sci. U.S.A. 64, 311–315.
Benda, P., Lightbody, J., Sato, G., Levine, L., and Sweet, S. (1968). Science 161, 370–371.
Buchmeier, M.J., Lewicki, H.A., Talbot, P.J., and Knobler, R.L. (1984). Virology 132, 261–270.
Cheever, F.S., Daniels, J.B., Pappenheimer, A.M., and Bailey, O.T. (1949) J. Exptl. Med. 90, 181–194.
Cheley, S., and Anderson, R. (1981). J. Gen. Virol. 54, 301–311.
Cheley, S. and Anderson, R. (1984) Anal. Biochem. 137, 15–19.
Cheley, S., Anderson, R., Cupples, M.J., Lee Chan, E.C.M., and Morris, V.L. (1981). Virology 112, 596–604.
Dubois-Dalcq, M.E., Doller, E.W., Haspel, M.V., and Holmes, K.V. (1982). Virology 119, 317–331.
Dulbecco, R., and Vogt, M. (1954). J. Exptl. Med. 99, 167–182.
Hirano, N., Goto, N., Ogawa, T., Ono, K., Murakami, T., and Fujiwara, K. (1980). Microbiol. Immunol. 24, 825–834.
Haspel, M.V., Lampert, P.W., and Oldstone, M.B.A. (1978). Proc. Natl. Acad. Sci. U.S.A. 75, 4033–4036.
Kit, S., Dubbs, D.R., Piekarski, L.J., and Hsu, T.C. (1963). Exptl. Cell Res. 31, 297–312.
LePrevost, C, Virelizier, J.L., and Dupuy, J.M. (1975). J. Immunol. 115, 640–643.
Lucas, A., Flintoff, W., Anderson, R., Percy, D., Coulter, M., and Dales, S. (1977). Cell 12, 553–560.
Manaker, R.A., Piczak, C.V., Miller, A.A., and Stanton, M.F. (1961). A J. Natl. Cancer Inst. 27, 29–51.
Merchant, D.J., and Hellman, K.B. (1962). Proc. Soc. Exptl. Biol. Med. 110, 194–198.
Mizzen, L., Cheley, S., Rao, M., Wolf, R., and Anderson, R. (1983). Virology 128, 407–417.
Nagashima, K., Wege, H., Meyermann, R., and ter Meulen, V. (1978). Acta Neuropathol. 45, 205–213.
Otsuki, K., and Tsubokura, M. (1981). Arch. Virol. 70, 315–320.
Rothfels, K.H., Axelrad, A.A., Siminovitch, L., McCulloch, E.A., and Parker, R.C. (1959). Can. Cancer Conf. 3, 189–214.
Schoellmann, G. and Shaw, E. (1963). Biochem. 2, 252–255.
Segal, D.M., Powers, J.C., Cowen, G.H., Davies, D.R., and Wilcox, P.E. (1971). Biochem. 10, 3728–3738.
Shaw, E., Mares-Guia, M., and Cohen, W. (1965). Biochem. 10, 2219–2224.
Sorensen, O., Coulter-Mackie, M.B., Puchalski, S., and Dales, S. (1984). Virology 137, 347–357.
Sorensen, O., Dugre, R., Percy, D., and Dales, S. (1982) Infect. Immun. 37, 1248–1260.
Sorensen, O., Percy, D., and Dales, S. (1980). Arch. Neurol. 37, 478–484.
Stohlman, S.A., and Weiner, L.P. (1981). Neurol. 31, 38–44.
Storz, J., Rott, R., and Kaluza, G. (1981). Infect. Immun. 31, 1214–1222.
Sturman, L.S., and Holmes, K.V. (1977). Virology 77, 650–660.
Sturman, L.S. and Holmes, K.V. (1984). In “Molecular Biology and Pathogenesis of Coronaviruses”, eds. Rottier, P.J.M, Van der Zeijst, B.A.M., Spaan, W.J.M. and Horzinek, M., pp. 25–35, Plenum Press, N.Y.
Toth, T.E. (1982). Amer. J. Vet. Res. 43, 967–972.
Wege, H., Siddell, S., and ter Meulen, V. (1982). Curr. Top. Microbiol. Immunol. 99, 165–200.
Weiner, L.P. (1973). Arch. Neurol. 28, 298–303.
Yasumura, Y., and Kawakita, Y. (1963). Nippon Rinsho (Japan) 21, 1209.
Yoshikura, H., and Tejima, S. (1981). Virology 113, 503–511.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Mizzen, L., Daya, M., Anderson, R. (1987). The Role of Protease-Dependent Cell Membrane Fusion in Persistent and Lytic Infections of Murine Hepatitis Virus. In: Lai, M.M.C., Stohlman, S.A. (eds) Coronaviruses. Advances in Experimental Medicine and Biology, vol 218. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1280-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1280-2_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1282-6
Online ISBN: 978-1-4684-1280-2
eBook Packages: Springer Book Archive